Cystic Brain Metastases Occurring in Anaplastic Lymphoma Kinase Gene Rearranged Non-Small-Cell Lung Cancer Patients Receiving Crizotinib

Clinical Lung Cancer

Volumn 17, Issue 1, 2016, Pages 85-90

  Narayanan, Vignesh ^a   Honce, M Justin ^a   Mehrotra, Sanjana ^a   Camidge, D Ross ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Anaplastic lymphoma kinase; Crizotinib; Cystic brain metastases; Non small cell lung cancer; Signet ring morphology

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; BRIGATINIB; CRIZOTINIB; PROTEIN TYROSINE KINASE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN CYST; BRAIN DAMAGE; BRAIN EDEMA; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CYSTIC BRAIN METASTASIS; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; FRONTAL LOBE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MALE; MIDDLE AGED; NEUROIMAGING; NON SMALL CELL LUNG CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PHASE 1 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; SMOKING; STEREOTACTIC RADIOSURGERY; SYSTEMIC DISEASE; SYSTEMIC THERAPY; TEMPORAL LOBE; BRAIN TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; LUNG NEOPLASMS; PATHOLOGY; PROGNOSIS; SECONDARY;

ADULT; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; GENE REARRANGEMENT; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PYRAZOLES; PYRIDINES; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84953367349     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2015.07.003     Document Type: Article

References (15)

1. A.T. Shaw, B.Y. Yeap, B.J. Solomon, and et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harboring ALK gene rearrangement: a retrospective analysis Lancet Oncol 12 2011 1004 1012
2. D.R. Camidge, Y.J. Bang, E.L. Kwak, and et al. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study Lancet Oncol 13 2012 1011 1019
3. S.G. Chun, K.S. Choe, P. Iyengar, and et al. Isolated central nervous system progression on crizotinib: an Achilles heel of non-small cell lung cancer with EML-4-ALK translocation? Cancer Biol Ther 13 2012 1376 1383
4. D.B. Costa, A.T. Shaw, S.H. Ou, and et al. Clinical experience with crizotinib in patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases J Clin Oncol 33 2015 1881 1888
5. D.B. Costa, S. Kobayashi, S.S. Pandya, and et al. CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib J Clin Oncol 29 2011 e443 e445
6. A.J. Weickhardt, B. Scheier, J.M. Burke, and et al. Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer J Thorac Oncol 7 2012 1807 1814
7. H. Hayashi, I. Okamoto, J. Tanizaki, and et al. Cystic brain metastasis in non-small-cell lung cancer with ALK rearrangement J Clin Oncol 32 2014 e122 e124
8. C. Saraceni, P.M. Li, J.F. Gainor, and et al. Cystic brain metastases in NSCLC harboring the EML4-ALK translocation after treatment with crizotinib J Thorac Oncol 10 2015 1116 1117
9. V. Sharma, K. Prabhash, V. Noronha, and et al. A systematic approach to the diagnosis of cystic brain lesions South Asian J Cancer 2 2013 98 101
10. + non-small cell lung cancer [abstract] J Clin Oncol 32 5(suppl) 2014 8047
11. R. Costa, R.B. Costa, C. Bacchi, and et al. Adenocarcinoma of the lung presenting with atypical cystic brain lesions BMJ Case Rep 2014 2014 1 3
12. Y.K. Zee, T.M. Chin, and A.S. Wong Fatal cystic change of brain metastasis after response to gefitinib in non-small-cell lung cancer J Clin Oncol 27 2009 e145 e146
13. H. Kaneda, I. Okamoto, K. Nakagawa, and et al. Rapid response of brain metastasis to crizotinib in a patient with ALK rearrangement-positive non-small cell lung cancer J Thorac Oncol 8 2013 e32 e33
14. A. Yoshida, K. Tsuta, H. Nakamura, and et al. Comprehensive histologic analysis of ALK-rearranged lung carcinomas Am J Surg Pathol 35 2011 1226 1234
15. M. Nishino, V.E. Klepeis, B.Y. Yeap, and et al. Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas Mod Pathol 25 2012 1462 1472